- Aegerion Pharmaceuticals (AEGR) CEO Marc Beer and COO Craig Fraser resign. Board member Sandford Drexel Smith takes over as interim CEO until a permanent successor is hired.
- The stock is still mired in a long-term downtrend. Shares are down ~83% from the peak of $101 in late 2013.